Have you evaluated the performance of Charles River Laboratories' (CRL) international operations during the quarter that concluded in September 2025? Considering the extensive worldwide presence of ...

Charles River Laboratories International, Inc. CRL reported second-quarter 2025 adjusted earnings per share (EPS) of $3.12, which rose 11.4% year over year. The figure surpassed the Zacks Consensus ...

Charles River Laboratories (CRL) reported $994.23 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 0.8%. EPS of $2.39 for the same period compares to $2 ...

Invesco Ltd‘s “Small Cap Value Fund” released its Q4 2025 investor letter. A copy of the letter can be downloaded here. The Invesco Small Cap Value Fund reported strong results for Q4 2025, ...